H

Henry Schein

Global healthcare product distributor and services

Physician Lab Sales Specialist

Full-Time
$100k - $135k+ Bonus
Senior
Bachelor's, Master's
Indianapolis, IN, USA+3 moreMore locations: Chicago, IL, USA | Milwaukee, WI, USA | Minneapolis, MN, USA
RemoteExtensive travel within the designated territory; 50% travel is not unusual.
Sales & Account ManagementField Sales

About the job

Requirements
  • Typically 7 or more years of increasing responsibility and complexity in applicable professional experience.
  • Demonstrated ability to meet or exceed revenue and unit targets.
  • Experience selling into physician office laboratories, urgent care centers, large group practices, and integrated delivery networks is preferred.
  • Prior experience collaborating within cross-functional teams to achieve multi-channel growth is preferred.
  • Demonstrated success exceeding quotas and driving territory growth in competitive markets.
  • Ability to close transactional consumables sales and longer-cycle moderate-complexity placements.
  • Familiarity with reagent rental models, CLIA compliance, and reimbursement frameworks.
  • Strong prospecting and territory management skills.
  • Bachelor's degree or global equivalent in a related discipline is typically expected; a Master's degree or global equivalent is preferred. May hold two or more industry certifications.
  • Laboratory or medical equipment sales experience is preferred; medical technology experience will also be considered.
  • Extensive travel within the designated territory is required; minimum 50% travel is not unusual.
  • Strategic, solution-oriented sales approach.
  • Excellent communication and presentation skills.
  • Strong analytical and problem-solving capabilities.
  • Understanding of industry practices and proficiency with relevant tools, systems, and procedures.
  • Planning and organizational skills; independent decision-making, analysis, and problem-solving skills.
  • Verbal and written communication, presentation, public speaking, and interpersonal skills.
  • Conflict resolution skills and ability to deliver difficult messages.
  • Ability to build partnerships at all levels within the company and cultivate lasting internal and external customer relationships.
  • Negotiation skills; ability to resolve complex issues effectively.
  • Project management and consultative skills, and ability to manage a budget.
  • Expertise in multiple technical and/or business skills.
Responsibilities
  • Drive sales growth by promoting laboratory instrumentation, reagents, consumables, and point-of-care testing solutions.
  • Deliver strategic account plans to maximize revenue, improve specialty penetration, and retain top-tier customers.
  • Coordinate multi-year reagent rental agreements and instrument placements within physician laboratories with field sales consultants, inside sales consultants, and executive selling teams to maximize wallet share and expand territory reach.
  • Build trusted-advisor relationships with physicians, laboratory directors, administrators, and decision-makers at physician office laboratories, urgent care centers, large group practices, community health centers, and integrated delivery networks.
  • Conduct diagnostic workflow analyses to identify opportunities to upgrade instrumentation, consolidate vendors, and improve reimbursement potential.
  • Target new accounts through data-driven prospecting.
  • Maintain knowledge of the CLIA regulatory landscape for waived, moderate, and high-complexity testing environments.
  • Monitor competitive activity and market shifts to inform strategy and identify white-space opportunities.
  • Serve as a laboratory diagnostics subject-matter expert to internal teams and provide product expertise.
Desired Qualifications
  • Laboratory or medical equipment sales experience; medical technology experience will also be considered.
  • Experience selling into physician office laboratories, urgent care centers, large group practices, and integrated delivery networks.
  • Prior experience collaborating within cross-functional teams to achieve multi-channel growth.
  • A Master's degree or global equivalent; may hold two or more industry certifications.

About the company

Henry Schein is a global supplier of healthcare products and services. It operates in two segments: healthcare distribution, which provides dental and medical consumables, equipment, and laboratory products to dentists, physicians, and veterinarians; and technology and value-added services, which offers practice management software, e-commerce solutions, and financial services. The company works by supplying healthcare professionals with a broad range of products and by offering software, online tools, and financing options to run their practices more efficiently. Compared with competitors, Henry Schein combines a wide product catalog with software and financial services, creating a one-stop platform for practice needs across more than 30 countries, with a strong focus on North America. Its goal is to be a trusted partner for healthcare professionals by supporting their day-to-day operations and growth through integrated distribution, technology, and financing solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Town of Huntington, New York

Founded

1932

Get referred to Henry Schein

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 sales reached $3.5 billion, and management raised full-year guidance.
  • Dentrix Ascend installs tripled since January 2025, with June's record new-customer month.
  • The $1.25 billion credit facility extends to September 19, 2031, funding buybacks and acquisitions.

What critics are saying

  • July 30, 2026 leadership restructuring exits three executives on October 30, 2026.
  • Henry Schein One faces Maryland and Utah lawsuits with filings continuing September 2026.
  • Q2 2026 restructuring expense hit $29 million; repeated charges pressure GAAP earnings.

What makes Henry Schein unique

  • Henry Schein One serves 90% of top 50 DSOs with recurring, high-margin software.
  • One Schein bundles distribution, exclusive brands like Curodont, and practice software.
  • Camlog, Biotech Dental, and Edge strengthen proprietary pricing against commodity distributors.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Company Match
  • Paid Vacation
  • Paid Parental Leave
  • Short Term Disability
  • Health Savings Account/Flexible Spending Account
  • Education Benefits

Growth & Insights and Company News

Headcount

6 month growth

7%

1 year growth

7%

2 year growth

7%
Yahoo Finance
Sep 30th, 2026
Henry Schein Cares celebrates 25 years with $285M in donations and product contributions

Henry Schein Cares, the corporate citizenship programme of Henry Schein, Inc., is celebrating its 25th anniversary. Since its launch in 2001, the programme has contributed more than $285 million in cash and donated products whilst collaborating with over 5,000 charitable partners worldwide. The programme operates through five pillars: catalysing healthcare access, advancing policies and solutions, relationship building, empowering Team Schein, and sustaining the planet. Key initiatives include supporting the American Dental Association Foundation's Give Kids A Smile programme, which has helped more than 10.2 million underserved children receive oral health services since 2003. Henry Schein celebrated the milestone during UN General Assembly Week in New York City. The company is advancing towards its Net Zero 2050 goal and aims to source 100% renewable energy by 2030.

TipRanks
Sep 22nd, 2026
Henry Schein expands credit facility to $1.25B, extends term to 2031

Henry Schein has amended and restated its revolving credit agreement, expanding aggregate commitments from $1 billion to $1.25 billion. The facility's termination date has been extended to 19 September 2031. The revised facility, arranged with a syndicate of major international banks, adjusts certain financial definitions and covenants. This provides the healthcare distribution company with greater flexibility in its capital structure. Henry Schein intends to use the enlarged credit facility for working capital and general corporate purposes. These include capital expenditures, share repurchases, refinancing existing debt, and funding potential acquisitions. The agreement includes customary representations, warranties, covenants, and events of default. The company supplies dental, medical, and animal health products to office-based practitioners and healthcare organisations in North America and international markets.

Yahoo Finance
Aug 31st, 2026
Henry Schein shares up 13% in Q2 as cost cuts and revenue growth support bullish outlook

MD Sass Concentrated Value Strategy highlighted Henry Schein as a notable contributor in its second-quarter 2026 investor letter. The healthcare solutions provider saw its shares appreciate 13% during the quarter. The asset management firm believes significant cost reductions combined with accelerating revenue growth should lead to material positive earnings revisions moving into the fourth quarter and 2027. MD Sass met with Henry Schein's new chief executive officer, Fred Lowery, and expects his distribution experience and operational approach to improve efficiencies, margins, and market share. The firm's estimates remain well above consensus over the next several years. Henry Schein closed at $89.52 per share on 28 August 2026, with a market capitalisation of $9.98 billion.

Yahoo Finance
Aug 13th, 2026
Henry Schein beats Q2 estimates with $3.46B revenue, raises full-year guidance on dental growth

Henry Schein reported second-quarter results that exceeded Wall Street expectations, with revenue of $3.46 billion versus analyst estimates of $3.37 billion and adjusted EPS of $1.27 versus $1.24 expected. The company attributed the performance to accelerating internal sales growth and robust gains in its global dental merchandise segment. CEO Frederick Lowery highlighted success in converting occasional buyers into regular customers and strong market share gains in the US and Canada. The company slightly raised its full-year adjusted EPS guidance to $5.34 at the midpoint. During the earnings call, analysts questioned the sustainability of US dental consumables growth and the timing of value creation benefits. CFO Ronald South indicated most operating income improvements from these initiatives would materialise in the second half of the year.

Yahoo Finance
Aug 4th, 2026
Henry Schein raises 2026 guidance after Q2 sales hit $3.5B on dental gains

Henry Schein reported second-quarter sales of $3.5 billion, up 6.7% year-over-year, driven by 4.6% internal local-currency growth and foreign exchange benefits. The healthcare distributor raised its full-year guidance following stronger-than-expected performance. GAAP net income rose to $94 million, or $0.82 per diluted share, from $86 million a year earlier. Non-GAAP earnings reached $1.27 per share, up 15.5% from $1.10 in the prior-year period. Operating margins expanded across all segments. GAAP operating margin increased 27 basis points to 4.94%, whilst non-GAAP operating margin grew 25 basis points to 7.21%. US dental merchandise sales climbed 8.3%, including 6.5% internal growth, with the company reporting market-share gains. Chief Executive Officer Fred Lowery attributed results to operational execution and early benefits from its value-creation programme.